Article Details
Retrieved on: 2022-09-10 07:20:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
2022-09-10 | NDAQ:PNT) POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ...
Article found on: stockhouse.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here